{"id":22410,"date":"2024-02-02T08:41:58","date_gmt":"2024-02-02T13:41:58","guid":{"rendered":"https:\/\/medicarereport.org\/?p=22410"},"modified":"2024-02-02T08:42:00","modified_gmt":"2024-02-02T13:42:00","slug":"3-charts-about-medicare-drug-price-negotiations","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=22410","title":{"rendered":"3 Charts About Medicare Drug Price Negotiations"},"content":{"rendered":"\n<p>(Chris Lee for The Kaiser Family Foundation published January 31, 2024)<\/p>\n\n\n\n<p>Under the Inflation Reduction Act, the federal government for the first time will negotiate directly with drug companies to determine the prices that Medicare will pay for certain high expenditure drugs covered under Medicare Part D (starting in 2026) and Part B (starting in 2028). Part D covers retail prescription drugs and Part B covers physician-administered medications.  Continue reading <a href=\"https:\/\/www.kff.org\/affordable-care-act\/press-release\/3-charts-about-medicare-drug-price-negotiations\/\" data-type=\"link\" data-id=\"https:\/\/www.kff.org\/affordable-care-act\/press-release\/3-charts-about-medicare-drug-price-negotiations\/\">here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"147\" height=\"138\" class=\"wp-image-7499\" style=\"width: 147px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/07\/Kaiser-Family-Foundation.jpg\" alt=\"\"><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:&nbsp;<\/strong>The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Chris Lee for The Kaiser Family Foundation published January 31, 2024) Under the Inflation Reduction Act, the federal government for<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32,21,20,53,15],"tags":[80,385,238,61,400,65,700],"class_list":["post-22410","post","type-post","status-publish","format-standard","hentry","category-cms","category-health-care-finance","category-health-care-redesign","category-hhs","category-part-dprescription-drugs","tag-cms","tag-healthcare-costs","tag-healthcare-finance","tag-medicare","tag-medicare-drug-price-negotiation-program","tag-medicare-part-d","tag-the-inflation-reduction-act"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22410","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22410"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22410\/revisions"}],"predecessor-version":[{"id":22411,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22410\/revisions\/22411"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}